Age limits on clinical trials need to be more flexible to allow more teenage cancer patients the chance to access new treatments. This is the finding of a report from the National Cancer Research Institute (NCRI), which was published in Lancet Oncology on 30 June 2014 entitled, 'Available, accessible, aware, appropriate, and acceptable: a strategy to improve participation of teenagers and young adults in cancer trials'.

Read full article